Filing Details

Accession Number:
0000899243-19-015285
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-31 16:17:53
Reporting Period:
2019-05-30
Accepted Time:
2019-05-31 16:17:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1731831 Eidos Therapeutics Inc. EIDX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1655016 C Jonathan Fox C/O Eidos Therapeutics, Inc.
101 Montgomery Street, Suite 2550
San Francisco CA 94104
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-30 5,000 $32.64 516,527 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. Represents the weighted average sale price of the shares sold ranging from $32.63 to $32.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  2. The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014.